Clinical trials recruiting for Mutation
4
Recruiting trials
0
US states with sites
3
Countries
25%
Accept healthy volunteers
Phase breakdown
Phase 2 1Phase 3 1Not applicable 2
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Crizotinib | 1 |
| Dabrafenib+Trametinib | 1 |
| Ensartinib | 1 |
| Everolimus | 1 |
| Glecirasib | 1 |
| Investigator's choice of chemotherapy | 1 |
| Larotrectinib | 1 |
| Pralsetinib | 1 |
| Pyrotinib | 1 |
| Savolitinib | 1 |
| Sunvozertinib | 1 |
Self-screener
Recruiting trials
- BioMEL- Diagnostic and Prognostic Factors in Melanoma.
- Everolimus With Investigator's Choice of Chemotherapy in Advanced Triple-Negative Breast Cancer (TNBC) With Luminal Androgen Receptor (LAR) Subtype
- Liquid Biopsy Evaluation and Repository Development at Princess Margaret
- Neoadjuvant Umbrella Trial for Patients With Unresectable Stage III NSCLC Harboring Rare Mutations.
Related conditions
Trials recruiting for Mutation often also study these conditions. Each links to its own recruiting-trial list.
Melanoma 487Lung cancer 2180Breast cancer 2239Uterine Cancer 10Triple-negative breast cancer 138Ovarian cancer 118Myeloma 3Metastatic breast cancer 131Lynch Syndrome 28Lymphoma 29
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Mutation trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.